Adenovirus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor (SR-AI) in LDL receptor knock-out mice

Atherosclerosis

Volumn 169, Issue 1, 2003, Pages 95-103

  Jalkanen, Johanna ^a   Leppänen, Pia ^a   Närvänen, Outi ^a   Greaves, David R ^b   Ylä Herttuala, Seppo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Atherogenesis; Gene therapy; LDL receptor knockout mice; Scavenger receptor

Indexed keywords

ADENOVIRUS VECTOR; GALACTOSAMINIDASE; LOW DENSITY LIPOPROTEIN RECEPTOR; RECOMBINANT DNA; SCAVENGER RECEPTOR; SECRETED DECOY MACROPHAGE SCAVENGER RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROGENESIS; BLOOD VESSEL WALL; CONTROLLED STUDY; DNA TRANSFER; HYPERCHOLESTEROLEMIA; INJECTION; KNOCKOUT MOUSE; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REDUCTION; SPECIES COMPARISON; STATISTICAL SIGNIFICANCE; TAIL; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

EID: 0038645127     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00155-2     Document Type: Article

References (35)

1. Greaves D.R., Gough P.J., Gordon S. Recent progress in defining the role of scavenger receptors in lipid transport, atherosclerosis and host defence. Curr. Opin. Lipidol. 9:1998;425-432.
2. Ylä-Herttuala S., Rosenfeld M.E., Parthasarathy S., et al. Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low-density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J. Clin. Invest. 87:1991;1146-1152.
3. Fraser I., Hughes D., Gordon S. Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature. 364:1993;343-346.
4. Platt N., Suzuki H., Kurihara Y., Kodama T., Gordon S. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc. Natl. Acad. Sci. USA. 93:1996;12456-12460.
5. Terpstra V., Kondratenko N., Steinberg D. Macrophages lacking scavenger receptor A show a decrease in binding and uptake of acetylated low-density lipoprotein and of apoptotic thymocytes, but not of oxidatively damaged red blood cells. Proc. Natl. Acad. Sci. USA. 94:1997;8127-8131.
6. el Khoury J., Thomas C.A., Loike J.D., Hickman S.E., Cao L., Silverstein S.C. Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors. J. Biol. Chem. 269:1994;10197-10200.
7. Suzuki H., Kurihara Y., Takeya M., et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 386:1997;292-296.
8. Park L., Raman K.G., Lee K.J., et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation end products. Nat. Med. 4:1998;1025-1031.
9. Bucciarelli L.G., Wendt T., Qu W., et al. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation. 106:2002;2827-2835.
10. Taguchi A., Blood D.C., del Toro G., et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature. 405:2000;354-360.
11. Ghivizzani S.C., Lechman E.R., Kang R., et al. Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc. Natl. Acad. Sci. USA. 95:1998;4613-4618.
12. Murase T., Kume N., Kataoka H., et al. Identification of soluble forms of lectin-like oxidized LDL receptor-1. Arterioscler. Thromb. Vasc. Biol. 20:2000;715-720.
13. Laukkanen J., Lehtolainen P., Gough P.J., Greaves D.R., Gordon S., Ylä-Herttuala S. Adenovirus-mediated gene transfer of a secreted form of human macrophage scavenger receptor inhibits modified low-density lipoprotein degradation and foam-cell formation in macrophages. Circulation. 101:2000;1091-1096.
14. Ishibashi S., Goldstein J.L., Brown M.S., Herz J., Burns D.K. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93:1994;1885-1893.
15. Plump A.S., Smith J.D., Hayek T., et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:1992;343-353.
16. Ylä-Herttuala S., Rosenfeld M.E., Parthasarathy S., et al. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 87:1990;6959-6963.
17. Leppänen P., Luoma J.S., Hofker M.H., Havekes L.M., Ylä-Herttuala S. Characterization of atherosclerotic lesions in apo E3-leiden transgenic mice. Atherosclerosis. 136:1998;147-152.
18. Palinski W., Rosenfeld M.E., Ylä-Herttuala S., et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86:1989;1372-1376.
19. Ylä-Herttuala S., Palinski W., Rosenfeld M.E., et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1989;1086-1095.
20. Bilheimer D.W., Eisenberg S., Levy R.I. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim. Biophys. Acta. 260:1972;212-221.
21. Goldstein J.L., Ho Y.K., Basu S.K., Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76:1979;333-337.
22. Kodama T., Freeman M., Rohrer L., Zabrecky J., Matsudaira P., Krieger M. Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature. 343:1990;531-535.
23. Brown M.S., Goldstein J.L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52:1983;223-261.
24. Sakaguchi H., Takeya M., Suzuki H., et al. Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. Lab. Invest. 78:1998;423-434.
25. Babaev V.R., Gleaves L.A., Carter K.J., et al. Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A. Arterioscler. Thromb. Vasc. Biol. 20:2000;2593-2599.
26. Wolle S., Via D.P., Chan L., Cornicelli J.A., Bisgaier C.L. Hepatic overexpression of bovine scavenger receptor type I in transgenic mice prevents diet-induced hyperbetalipoproteinemia. J. Clin. Invest. 96:1995;260-272.
27. de Winther M.P., Gijbels M.J., van Dijk K.W., et al. Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3 Leiden transgenic mice. Atherosclerosis. 144:1999;315-321.
28. Hiltunen M.O., Turunen M.P., Turunen A.M., et al. Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods. FASEB J. 14:2000;2230-2236.
29. Wilson J.M. Adenovirus-mediated gene transfer to liver. Adv. Drug Deliv. Rev. 46:2001;205-209.
30. Michou A.I., Santoro L., Christ M., Julliard V., Pavirani A., Mehtali M. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther. 4:1997;473-482.
31. Wang Q., Greenburg G., Bunch D., Farson D., Finer M.H. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector. Gene Ther. 4:1997;393-400.
32. Laukkanen M.O., Leppanen P., Turunen P., Porkkala-Sarataho E., Salonen J.T., Yla-Herttuala S. Gene transfer of extracellular superoxide dismutase to atherosclerotic mice. Antioxid. Redox Signal. 3:2001;397-402.
33. Quarck R., De Geest B., Stengel D., et al. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice. Circulation. 103:2001;2495-2500.
34. Ylä-Herttuala S., Martin J.F. Cardiovascular gene therapy. Lancet. 355:2000;213-222.
35. Oka K., Pastore L., Kim I.H., et al. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor. Circulation. 103:2001;1274-1281.